Stay updated on Eli Lilly and Company Press Releases

Sign up to get notified when there's something new on the Eli Lilly and Company Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Eli Lilly and Company Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    Three new press releases were added to the page, announcing conference participation, a community sports initiative, and UNICEF collaboration, each with their datelines; at the same time, three items were removed, including the Kelonia Therapeutics acquisition, the Q1 2026 earnings conference date, and ACHIEVE-4 safety updates.
    Difference
    8%
    Check dated 2026-05-20T20:45:12.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Adds new entries about weight-loss trial results for Foundayo and lower-dose Zepbound, and announces Lilly's philanthropic initiative tied to its 150th anniversary. It also removes several older entries from the listing, narrowing the feed to more recent announcements.
    Difference
    8%
    Check dated 2026-05-13T16:20:30.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    New press releases and corporate updates have been added to the Lilly press releases page, including Omvoh UC disease clearance data, a Q1 2026 financial update, a second-quarter dividend declaration, and several acquisitions. Older items, such as Foundayo pricing details and Centessa acquisition content, have been removed.
    Difference
    8%
    Check dated 2026-05-06T12:05:25.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    New addition: Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera, including AJ1-11095 details. Deletion: removal of the press release detailing Taltz plus Zepbound efficacy in psoriatic arthritis and obesity.
    Difference
    2%
    Check dated 2026-04-29T09:24:59.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    New press releases have been added to the listing, including Lilly’s planned acquisition of Kelonia Therapeutics, additional details on Kelonia’s early CAR‑T program, and a saved financial results announcement date. Also added are entries for recent clinical-study updates involving Foundayo (orforglipron), while older press-release items related to EBGLYSS, retatrutide, and Zepbound KwikPen access appear removed from the current visible list.
    Difference
    8%
    Check dated 2026-04-22T05:00:34.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    New press releases about Jaypirca trial results and Foundayo availability with pricing were added, while older items and warnings were removed from the page.
    Difference
    8%
    Check dated 2026-04-15T02:04:09.000Z thumbnail image

Stay in the know with updates to Eli Lilly and Company Press Releases

Enter your email address, and we'll notify you when there's something new on the Eli Lilly and Company Press Releases page.